Search

Your search keyword '"Drugs -- Economic aspects"' showing total 153 results
Start Over Descriptor "Drugs -- Economic aspects" Topic medical economics -- economic aspects
153 results on '"Drugs -- Economic aspects"'

2. MrMed brings medicines on a budget

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Mass communications
Abstract

Byline: BestMediaInfo Bureau Delhi: MrMed has launched its second digital campaign with the message: 'Dava budget mein bhi hai, aur pahunch mein bhi'-- medicines that are both affordable and accessible,' [...]

Published
2024

3. Reliance Rx Partners with Waltz Health to Lower Costs of Specialty Medications

Subjects
Medical economics -- Economic aspects, Drugstores -- Alliances and partnerships, Drugs -- Economic aspects, Health insurance -- Economic aspects, Business, Business, international
Abstract

Reliance Rx joins the Waltz Connect marketplace as an in-network pharmacy option for specialty prescriptions. CHICAGO & BUFFALO, N.Y. -- Waltz Health, a digital health company developing smarter, technology-enabled ways [...]

Published
2024

4. 'Clinic-on-Wheels' programme providing free of cost medicines

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, General interest, News, opinion and commentary
Abstract

Deputy Commissioner Hafizabad Sundas Irshad said that Clinic on Wheal programme of the Chief Minister Punjab Maryam Nawaz Sharif for providing free of cast medicines and other treatment facilities to [...]

Published
2024

5. Nigeria: Forex Devaluation Contributes to Rising Cost of Drugs in Nigeria - Minister

Subjects
Medical economics -- Economic aspects, Foreign exchange -- Economic aspects, Drugs -- Economic aspects, Cabinet officers -- Economic aspects, Logistics -- Economic aspects, News, opinion and commentary
Abstract

Byline: Leshi James and Mariam Ileyemi Other factors contributing to the escalating cost of drugs, according to the Minister, include power supply, technology, the supply chain and the regulatory landscape. [...]

Published
2024

7. Low Cost Purchase Of Medicines

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Business, international
Abstract

Low cost purchase of medicines Low cost purchase of medicines Major organization: I.M.-S.P. CENTRUL DE SANATATE TOMAI Address: I.M.-S.P. CENTRUL DE SANATATE TOMAI Country:Moldova, Republic of Email: maya.yalama@mail.ru Tender notice [...]

Published
2024

8. Framework Agreement For The Supply Of Medicines Pn3 - Volume Cost 2024 2025 1

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Tenders are invited for framework agreement for the supply of medicines pn3 - volume cost 2024 2025 1 The framework agreement has as its object the conclusion of subsequent contracts [...]

Published
2024

9. Framework Agreement For The Supply Of Medicines Pn3 - Volume Cost 2024 2025 1

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Tenders are invited for framework agreement for the supply of medicines pn3 - volume cost 2024 2025 1 The framework agreement has as its object the conclusion of subsequent contracts [...]

Published
2024

11. Nigeria: Exchange Rate Taking Cost of Drugs Beyond Reach of Nigerians - NMA

Subjects
Medical economics -- Economic aspects, Foreign exchange -- Economic aspects, Drugs -- Economic aspects, Money -- Economic aspects, News, opinion and commentary
Abstract

Byline: Rotimi Ojomoyela The Chairman of the Nigerian Medical Association, NMA, in Ekiti State, Dr. Babatunde Rosiji, yesterday, decried the high rate of foreign exchange, saying that the development is [...]

Published
2023

12. Subsequent Contract For The Supply Of Medicines Pn3 Oncology - Cost Volume 2022-2023-4

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Contract agreement, Business, international
Abstract

Contract awarded: Subsequent contract for the supply of medicines pn3 oncology - cost volume 2022-2023-4 Framework agreement for the supply of medicines pn3 oncology - cost volume 2022 2023 4 [...]

Published
2023

15. United States : Tester Introduces Bill to Lower Drug Costs for Medicare Patients, Hold Massive PBM Corporations Accountable

Subjects
Medicare -- Economic aspects, Medical economics -- Economic aspects, Bills, Legislative -- Economic aspects, Drugs -- Economic aspects, Business, international
Abstract

U.S. Senator Jon Tester introduced his bipartisan Patients Before Middlemen (PBM) Act bill to lower drug costs and prevent massive Pharmacy Benefit Managers (PBMs) from price gouging Medicare Part D [...]

Published
2023

16. Framework Agreement For The Supply Of Medicines Pn3 Oncology - Cost Volume 2023 2024 2

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Contract notice: framework agreement for the supply of medicines pn3 oncology - cost volume 2023 2024 2 The purpose of the framework agreement is to conclude subsequent contracts for the [...]

Published
2023

18. Reimbursement Of Costs For Discounted Medicines Under The 'program Of Free And Discounted Medicines In Case Of Outpatient Treatment Of Certain Groups Of The Population And For Certain Categories Of Di

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Business, international
Abstract

Contract awarded for Reimbursement of costs for discounted medicines under the 'program of free and discounted medicines in case of outpatient treatment of certain groups of the population and for [...]

Published
2023

19. Ukraine : Ministry of Health: The list of medicines, the cost of which is covered from the budget within the framework of the state guarantee program, has been expanded

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Cabinet officers -- Economic aspects, Company financing, Business, international
Abstract

at the Government meeting, the resolution of the Cabinet of Ministers of Ukraine 'On Amendments to the National List of Essential Medicines' was adopted. Its purpose is to expand the [...]

Published
2023

20. Framework Agreement For The Supply Of Medicines Pn3 Oncology - Cost Volume 2023 2024 1

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Contract notice: framework agreement for the supply of medicines pn3 oncology - cost volume 2023 2024 1 The purpose of the framework agreement is to conclude subsequent contracts for the [...]

Published
2022

22. Framework Agreement For The Supply Of Medicines Pn3 Oncology - Cost Volume 2022 2023 5

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Contract notice: framework agreement for the supply of medicines pn3 oncology - cost volume 2022 2023 5 The purpose of the framework agreement is to conclude subsequent contracts for the [...]

Published
2022

23. Framework Agreement For The Supply Of Pn3 Oncology Medicines - Volume Cost 2022 - 2023 - 4

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Contract notice: framework agreement for the supply of pn3 oncology medicines - volume cost 2022 - 2023 - 4 The framework agreement has as object the conclusion of subsequent contracts [...]

Published
2022

25. Medicine Costs for Ukrainian Refugees in Poland Covered by New Direct Cash Aid Program

Subjects
Social service -- Economic aspects, Medical economics -- Economic aspects, Drugstores -- Economic aspects, Drugs -- Economic aspects, Health care industry -- Economic aspects, Pharmacy -- Economic aspects, Health care industry, Business, News, opinion and commentary
Abstract

With $10 Million Commitment, Direct Relief and Pelion S.A. Will Cover Costs of Medicines at Pharmacies Across Poland WARSAW, Poland, April 15, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3506520-1&h=3173870716&u=https%3A%2F%2Fwww.directrelief.org%2Fnews%2F&a=Direct+Relief and https://c212.net/c/link/?t=0&l=en&o=3506520-1&h=68893850&u=https%3A%2F%2Fwww.pelion.eu%2Fen%2F&a=Pelion+S.A. today announced [...]

Published
2022

26. Framework Agreement For The Supply Of Pn3 Oncology Medicines - Cost Volume 2022-2023-2

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Contract notice: framework agreement for the supply of pn3 oncology medicines - cost volume 2022-2023-2 The purpose of the framework agreement is to conclude subsequent contracts for the purchase of [...]

Published
2022

27. Medicine cost reimbursement program includes 62 new medicines

Subjects
Medical economics -- Economic aspects, Diabetes therapy -- Economic aspects, Drugs -- Economic aspects, Mental illness -- Economic aspects, Business, Business, international, News, opinion and commentary
Abstract

Medicine cost reimbursement program includes 62 new medicines KYIV. Oct 5 (Interfax-Ukraine) - Since October 1, some 62 new medicines have been included in the Affordable medicines reimbursement program. According [...]

Published
2021

28. 'Profit over death': millions of American diabetics struggle to afford insulin; Trump issued executive orders in 2020 aimed at cutting cost of medicine, but activists say they have accomplished little

Subjects
Walmart Inc., Activists -- Economic aspects, Drugs -- Economic aspects, Medically uninsured persons -- Economic aspects, Medical economics -- Economic aspects, Health insurance -- Economic aspects, Diabetics -- Economic aspects, News, opinion and commentary
Abstract

Byline: Michael Sainato Dan Hart lost his job as a bartender in Philadelphia, Pennsylvania, when the coronavirus pandemic hit in March, making it even harder to afford the insulin he [...]

Published
2020

29. Medicare is set to decide whether it should pay for controversial new Alzheimers drug that costs patients $56,000 a year

Subjects
United States. Food and Drug Administration, United States. Centers for Medicare and Medicaid Services, Biogen Inc., Biological products industry -- Economic aspects, Medical economics -- Economic aspects, Medicare -- Economic aspects, Alzheimer's disease -- Drug therapy -- Economic aspects, Drugs -- Economic aspects, Drug approval -- Economic aspects, Business, international, Law, Aduhelm (Medication)
Abstract

Medicare launched a formal process on Monday to decide whether or not to cover Aduhelm, the controversial newly approved Alzheimer's drug developed by Biogen. The drug will cost patients individual [...]

Published
2021

30. Framework Agreement For The Supply Of Pn3 Oncology Medicines - Volume Cost - 2020-2021 (romania-trgovite: Antineoplastic Agents)

Subjects
Medical economics -- Economic aspects, Drugs -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Business, international
Abstract

Contract award notice: Framework agreement for the supply of pn3 oncology medicines - volume cost - 2020-2021 (romania-trgovite: Antineoplastic agents) The framework agreement has as object the conclusion of subsequent [...]

Published
2021

31. Three strategies for controlling pharmacy benefit costs: effective auditing, innovative plan design, and increased focus on controlling aspects of member behavior can set the stage for reducing future cost trends in pharmacy plans

Author

Malhotra, Ritu and Brandle, Sean M.

Subjects
Medical care, Cost of -- Economic aspects, Medical economics -- Economic aspects, Drugs -- Economic aspects, Cost control -- Economic aspects, Cost reduction, Banking, finance and accounting industries, Business, Government
Abstract

As public-sector health plan sponsors struggle with increasing pharmacy plan costs, effective auditing, innovative plan design, and increased focus on controlling aspects of member behavior can set the stage for [...]

Published
2011

32. New model will reduce Medicare Part B drugs costs, save taxpayers $85 billion over seven years

Subjects
United States. Department of Health and Human Services, Medicare -- Economic aspects, Drugs -- Economic aspects, Medical economics -- Economic aspects, Pharmaceutical policy -- Economic aspects, News, opinion and commentary, Sports and fitness
Abstract

(The Center Square) - President Donald Trump and the U.S. Department of Health and Human Services announced a new drug payment model Friday that will significantly lower the cost of [...]

Published
2020

33. Coronavirus - Africa: COVID-19 could affect the availability and cost of antiretroviral medicines, but the risks can be mitigated

Subjects
Highly active antiretroviral therapy -- Economic aspects, Coronaviruses -- Economic aspects, Drugs -- Economic aspects, Antiretroviral agents -- Economic aspects, Medical economics -- Economic aspects, COVID-19 -- Economic aspects, Business, Business, international
Abstract

M2 PRESSWIRE-June 22, 2020-: Coronavirus - Africa: COVID-19 could affect the availability and cost of antiretroviral medicines, but the risks can be mitigated (C)1994-2020 M2 COMMUNICATIONS RDATE:22062020 UNAIDS study shows [...]

Published
2020

34. FAS PROPOSES MEASURES TO SUPPORT MEDICINES THAT COSTS UP TO 100 RU

Subjects
Drugs -- Economic aspects, Medical economics -- Economic aspects, Pharmaceutical industry, Production management, News, opinion and commentary
Abstract

MOSCOW, Russia -- The following information was released by the Federal Antimonopoly Service of the Russian Federation: A systemic approach proposed by the antimonopoly body will reduce the risk of [...]

Published
2020

35. Dr Matthew Offord ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the retail cost of (a) baby food, (b) infant formula and (c) infant medication does not rise disproportionately as a result of the covid-19 outbreak

Subjects
Drugs -- Economic aspects, Medical economics -- Economic aspects, Business, international
Abstract

London: UK Parliament has issued the following written answer: Answered by: Jo Churchill Answered on: 27 April 2020 The Department does not set the retail prices for baby food and [...]

Published
2020

36. Mako Medical Caps Pharmacy Cost for Over 300 Medications

Subjects
Medical economics -- Economic aspects, Drugstores -- Economic aspects -- Finance, Drugs -- Economic aspects, Pharmacy -- Economic aspects, Medical laboratories -- Economic aspects, Company financing, Business, News, opinion and commentary
Abstract

MakoRx's new disruptive pharmacy subscription model provides access to over 300 medications for free CHARLESTON, S.C., Feb. 7, 2020 /PRNewswire/ -- Mako Medical Laboratories through MakoRx launched a new pharmacy [...]

Published
2020

37. Three Harvard experts explain how economics can shape precision medicines

Subjects
Precision medicine -- Economic aspects, Physical fitness -- Economic aspects, Cancer -- Care and treatment -- Economic aspects, Drugs -- Economic aspects, Medical research -- Economic aspects, Medical economics -- Economic aspects, Business schools -- Economic aspects, Medical schools -- Economic aspects, Health, Harvard University. Graduate School of Business Administration
Abstract

2017 APR 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Author affiliations: Harvard Business School, Harvard Medical School, Dana-Farber/Brigham and Women's Cancer [...]

Published
2017

38. 'The challenge in American medicine is one of economics and mathematics and less about politics'; Q&A Dr. Robert Pearl

Subjects
Medical records -- Economic aspects, Drugs -- Economic aspects, Medical practice -- Economic aspects, Questions and answers -- Economic aspects, Medical economics -- Economic aspects, Health maintenance organizations -- Economic aspects, Business, Health care industry
Abstract

Byline: Gregg Blesch Dr. Robert Pearl leads the 9,000 physicians employed by the Permanente Medical Group, which serves over 4 million Kaiser Permanente members in California and around Washington, D.C. [...]

Published
2017

39. Express Scripts Sees Slower Annual Growth in Drug Costs

Subjects
Express Scripts Inc. -- Growth, Drugs -- Economic aspects, Liver diseases -- Economic aspects, Hepatitis C -- Economic aspects, Medical economics -- Economic aspects, Health maintenance organizations -- Economic aspects -- Growth, Prescriptions (Drugs) -- Economic aspects, Company growth, Health
Abstract

Express Scripts on Monday reported evidence of lower growth in consumers' costs for prescription medicines, aided by a drop in the cost of hepatitis medicines. Spending on prescription drugs increased [...]

Published
2017

40. India Supplying Lowest Cost Hepatitis C Medicines for 1.4 Billion Citizens

Subjects
Sofosbuvir -- Economic aspects, Drugs -- Economic aspects, Velpatasvir -- Economic aspects, Hepatitis C -- Economic aspects, Medical economics -- Economic aspects, Medical supplies, Medical tourism, Health, Public health, Business, Business, international, World Health Organization
Abstract

M2 PRESSWIRE-December 17, 2019-: India Supplying Lowest Cost Hepatitis C Medicines for 1.4 Billion Citizens (C)1994-2019 M2 COMMUNICATIONS RDATE:16122019 India is now offering superior quality services in the field of [...]

Published
2019

41. CASTEN VOTES TO LOWER THE COST OF PRESCRIPTION DRUGS

Subjects
Drugs -- Economic aspects, Social services -- Economic aspects, Medical economics -- Economic aspects, Health insurance industry -- Economic aspects, Prescriptions (Drugs) -- Economic aspects, Inflation (Economics), Insurance industry, Medicare, Insurance companies, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the office of Illinois Rep. Sean Casten: Today, U.S. Representative Sean Casten (IL-06) voted for the bipartisan H.R.3, the Elijah E. Cummings [...]

Published
2019

42. STEFANIK HELPS INTRODUCE, SUPPORTIVE OF ALTERNATIVE TO PELOSI'S DRUG PRICING BILL THE LOWER COSTS, MORE CURES ACT

Subjects
Congressional representatives -- Economic aspects, Pricing -- Economic aspects, Drugs -- Economic aspects, Medical economics -- Economic aspects, Pharmaceutical policy -- Economic aspects, Legislators, Product price, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the office of New York Rep. Elise Stefanik: Congresswoman Elise Stefanik is an original cosponsor to H.R. 19, the Lower Costs, More [...]

Published
2019

43. REP. CARTWRIGHT STATEMENT ON UPCOMING VOTE TO LOWER DRUG COSTS FOR AMERICANS

Subjects
Drugs -- Economic aspects, Medical economics -- Economic aspects, Prescriptions (Drugs) -- Economic aspects, Savings, Family, Medicare, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the office of Pennsylvania Rep. Matthew Cartwright: Today, U.S. Representative Matt Cartwright (PA-08) issued the following statement on the upcoming House of [...]

Published
2019

44. COMBATTING MEDICINE'S SKYROCKETING COST

Subjects
Drugs -- Economic aspects, Medical economics -- Economic aspects, Prescriptions (Drugs) -- Economic aspects, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the office of New York Rep. Joseph Morelle: Under no circumstance should a family or individual have to forego meeting their most [...]

Published
2019

45. CHAIRMAN NEAL ANNOUNCES A HEARING ON INVESTING IN THE U.S. HEALTH SYSTEM BY LOWERING DRUG PRICES, REDUCING OUT-OF-POCKET COSTS, AND IMPROVING MEDICARE BENEFITS

Subjects
Chairpersons -- Economic aspects, Medicare -- Economic aspects, Drugs -- Economic aspects, Medical economics -- Economic aspects, Health care reform -- Economic aspects, Health insurance, Retirement benefits, Company investment, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the Committee on Ways and Means: House Ways and Means Committee Chairman Richard E. Neal announced today that the Committee will hold [...]

Published
2019

46. Lawmaker urges firms to lower cost of medicines to help end TB epidemic in Africa

Subjects
Epidemics -- Africa -- Kenya -- Economic aspects, Drugs -- Economic aspects, National health insurance -- Economic aspects, Microbial drug resistance -- Economic aspects, Medical economics -- Economic aspects, Tuberculosis -- Economic aspects, Caucuses, Health insurance, Antitubercular agents, Pharmaceutical industry, Drug resistance, Business, general, General interest, News, opinion and commentary
Abstract

NAIROBI, September 13, 2019 (Xinhua via COMTEX) -- Multinational pharmaceutical firms should lower the cost of medicines to help end the tuberculosis (TB) epidemic in Africa, a lawmaker said on [...]

Published
2019

47. Warwick spinout, Stoli Catalysts, wins EU1.2m to halve the cost of making medicines, vitamins and food supplements

Subjects
Drugs -- Economic aspects, Catalysts -- Economic aspects, Vitamins -- Economic aspects, Medical economics -- Economic aspects, Dietary supplements -- Economic aspects, Small and medium sized companies, Industrial research, Business, international, University of Warwick
Abstract

London: University of Warwick, UK Government has issued the following news release: - Stoli Catalysts, a spinout company from the University of Warwick's School of Engineering has been awarded a [...]

Published
2019

48. Generic And Low Cost Branded Drugs And Medicines, Injectable, Surgical Including Disposable And Consumable Items Etc. For Bsby And Other Schemes Of Gor|goi On The Basis Of Maximum Discount On Mrp

Subjects
Drugs -- Economic aspects, Medical economics -- Economic aspects, Generic drugs, Legal fees, Business, international
Abstract

Tenders are invited for generic and low cost branded drugs and medicines, injectable, surgical including disposable and consumable items etc. for bsby and other schemes of gor/goi on the basis [...]

Published
2019

49. Big Variation In Part D Costs Means Most Medicare Beneficiaries Overpay for Prescriptions, Says New Analysis by The Senior Citizens League

Subjects
Medicare -- Economic aspects, Drugs -- Economic aspects, Prescription drug plans -- Economic aspects, Elderly -- Economic aspects, Medical economics -- Economic aspects, Price gouging -- Economic aspects, Prescriptions (Drugs) -- Economic aspects, Social security, Beneficiaries, Business, general
Abstract

WASHINGTON (PRWEB) July 25, 2019 A new analysis from The Senior Citizens League (TSCL) of 12 frequently - prescribed drugs illustrates that Medicare recipients frequently overpay for their medications. 'Because [...]

Published
2019

50. Generic And Low Cost Branded Drugs And Medicines, Injectable, Surgical Including Disposable And Consumable Items Etc. For Bsby And Other Schemes Of Gor|goi On The Basis Of Maximum Discount On Mrp

Subjects
Drugs -- Economic aspects, Medical economics -- Economic aspects, Generic drugs, Legal fees, Business, international
Abstract

Tenders are invited for generic and low cost branded drugs and medicines, injectable, surgical including disposable and consumable items etc. for bsby and other schemes of gor/goi on the basis [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results